Christopher W. Cain
Independent DirectorDr. Christopher W. Cain, Ph.D., also known as Chris, serves as Independent Director at Damora Therapeutics, Inc. (formerly known as Galecto, Inc.) since November 10, 2025. He is an Independent Director of Jade Biosciences, Inc. since July 2024. Dr. Cain is Director of Viridian Therapeutics, Inc. from March 10, 2025. Dr. Cain has been Independent Director of Cogent Biosciences, Inc. (formerly known as Unum Therapeutics Inc.) since July 6, 2020 & Jade Biosciences, Inc also. Dr. Cain has serves as Director of Research at Fairmount Funds Management LLC, a healthcare investment fund, since April 2020. From February 2019 to February 2020, Dr. Cain served as Vice President at Samsara BioCapital. He was a Senior Associate at Apple Tree Partners till February 2019. He was an Associate at RA Capital Management, LLC from November 2014 to May 2016. Previously, he was a writer and editor at BioCentury Publications and the Science-Business eXchange, where he evaluated the clinical and commercial potential of novel molecular targets and drug platforms emerging from academic labs. Dr. Cain served at Apple Tree Partners, a life sciences-focused venture capital fund, from July 2016 to January 2019, most recently as Senior Associate. Dr. Cain served at BioCentury Publications from June 2010 to October 2014, most recently as Associate Editor. Prior to BioCentury, he was a researcher at the University of California, where his work focused on understanding the transcriptional regulation and evolution of morphological change in fungi including the pathogen Candida albicans. He holds a B.A. in Biology from the University of California, Santa Barbara, College of Creative Studies. He earned his Ph.D. in Biochemistry and Molecular Biology from the University of California, San Francisco, where he was awarded a Genentech Graduate Fellowship.
Positions
- Company NameDamora Therapeutics, Inc.Stock CodeDMRAPositionIndependent DirectorColleagues
- GWGarrett WinslowSenior VP, General Counsel & Corporate Secretary
- PEPeter Evan HarwinIndependent Chairman of the Board
- JAJennifer A. JarrettCEO, President & Director
- UJUlf J. NilssonCo-Founder
- HLHakon LefflerCo-Founder
- TSTariq SethiCo-Founder
- MLMichael LandsittelIndependent Director
- JFJonathan FallowfieldMember of Clinical Advisory Board – Liver cirrhosis
